Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
88.00
+3.14 (3.70%)
At close: Oct 9, 2025, 4:00 PM EDT
90.88
+2.88 (3.27%)
After-hours: Oct 9, 2025, 5:23 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $6.35 billion as of October 9, 2025. Its market cap has decreased by -11.21% in one year.
Market Cap
6.35B
Enterprise Value
5.34B
1-Year Change
-11.21%
Ranking
Category
Stock Price
$88.00
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $6.35B, an increase of 697.17%. That is a compound annual growth rate of 63.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 6.35B | 14.08% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |